Turn nucleation perturbs amyloid β self-assembly and cytotoxicity

Journal of Molecular Biology

Volumn 421, Issue 2-3, 2012, Pages 315-328

  Doran, Todd M ^a   Anderson, Elizabeth A ^a   Latchney, Sarah E ^b   Opanashuk, Lisa A ^b   Nilsson, Bradley L ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Alzheimer's disease; amyloid ; fibril self assembly; turn nucleation; hairpin

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[24-27]; OLIGOMER; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FIBER; MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN MOTIF; PROTEIN STRUCTURE; THERMODYNAMICS; THERMOSTABILITY;

EID: 84863989935     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2012.01.055     Document Type: Article

References (72)

1. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
2. Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases Nat. Rev. Neurosci. 4 2003 49 60
3. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 75 2006 333 366
4. Jakob-Roetne R., and Jacobsen H. Alzheimer's disease: from pathology to therapeutic approaches Angew. Chem. Int. Ed. 48 2009 3030 3059
5. Roychaudhuri R., Yang M., Hoshi M.M., and Teplow D.B. Amyloid β-protein assembly and Alzheimer disease J. Biol. Chem. 284 2009 4749 4753
6. Campioni S., Mannini B., Zampagni M., Pensalfini A., Parrini C., and Evangelisti E. A causative link between the structure of aberrant protein oligomers and their toxicity Nat. Chem. Biol. 6 2010 140 147
7. Ittner L.M., and Gotz J. Amyloid-β and tau - a toxic pas de deux in Alzheimer's disease Nat. Rev. Neurosci. 12 2011 67 72
8. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., and Ostaszewski B.L. Amyloid β-peptide is produced by cultured cells during normal metabolism Nature 359 1992 322 325
9. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., and Davis D. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids Nature 359 1992 325 327
10. Shoji M., Golde T.E., Ghiso J., Cheung T.T., Estus S., and Shaffer L.M. Production of the Alzheimer amyloid β protein by normal proteolytic processing Science 258 1992 126 129
11. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., and Wolfe M.S. Naturally secreted oligomers of amyloid-β protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
12. Walsh D.M., and Selkoe D.J. Aβ oligomers - a decade of discovery J. Neurochem. 101 2007 1172 1184
13. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., and Zurdo J. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 416 2002 507 511
14. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
15. Ahmed M., Davis J., Aucoin D., Sato T., Ahuja S., and Aimoto S. Structural conversion of neurotoxic amyloid-β(1-42) oligomers to fibrils Nat. Struct. Mol. Biol. 17 2010 561 567
16. Kelly J. Mechanisms of amyloidogenicity Nat. Struct. Biol. 7 2000 824 826
17. Hamley I.W. Peptide fibrillization Angew. Chem. Int. Ed. 46 2007 8128 8147
18. Senguen F.T., Lee N.R., Gu X., Ryan D.M., Doran T.M., Anderson E.A., and Nilsson B.L. Probing aromatic, hydrophobic and steric effects on the self-assembly of an amyloid-β fragment peptide Mol. BioSyst. 7 2011 486 496
19. Senguen F.T., Doran T.M., Anderson E.A., and Nilsson B.L. Clarifying the influence of core amino acid hydrophobicity, secondary structure propensity, and molecular volume on amyloid-β 16-22 self-assembly Mol. BioSyst. 7 2011 497 510
20. Zhang S., Iwata K., Lachenmann M.J., Peng J.W., Li S., and Stimson E.R. The Alzheimer's peptide Aβ adopts a collapsed coil structure in water J. Struct. Biol. 130 2000 130 141
21. Balbach J.J., Petkova A.T., Oyler N.A., Antzutkin O.N., Gordon D.J., Meredith S.C., and Tycko R. Supramolecular structure in full-length Alzheimer's β-amyloid fibrils: evidence for a parallel β-sheet organization from solid-state nuclear magnetic resonance Biophys. J. 83 2002 1205 1216
22. Petkova A.T., Leapman R.D., Guo Z., Yau W.M., Mattson M.P., and Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils Science 307 2005 262 265
23. Petkova A.T., Yau W.M., and Tycko R. Experimental constraints on quaternary structure in Alzheimer's β-amyloid fibrils Biochemistry 45 2006 498 512
24. Paravastu A.K., Leapman R.D., Yau W.M., and Tycko R. Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils Proc. Natl Acad. Sci. USA 105 2008 18349 18354
25. Tycko R., Sciaretta K.L., Orgel J.P.R.O., and Meredith S.C. Evidence for novel β-sheet structures in Iowa mutant β-amyloid fibrils Biochemistry 48 2009 6072 6084
26. Tycko R. Solid-state NMR studies of amyloid fibril structure Annu. Rev. Phys. Chem. 62 2011 279 299
27. Lazo N.D., Grant M.A., Condron M.C., Rigby A.C., and Teplow D.B. On the nucleation of amyloid β-protein monomer folding Protein Sci. 14 2005 1581 1596
28. Lührs T., Ritter C., Adrian M., Riek-Loher D., Bohrmann B., and Döbeli H. 3D structure of Alzheimer's amyloid-β(1-42) fibrils Proc. Natl Acad. Sci. USA 102 2005 17342 17347
29. Whittemore N.A., Mishra R., Kheterpal I., Williams A.D., Wetzel R., and Serpersu E.H. Hydrogen-deuterium (H/D) exchange mapping of Aβ(1-40) amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy Biochemistry 44 2005 4434 4441
30. Habicht G., Haupt C., Friedrich R.P., Hortschansky P., Sachse C., and Meinhardt J. Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrils Proc. Natl Acad. Sci. USA 104 2007 19232 19237
31. Sgourakis N.G., Yan Y., McCallum S.A., Wang C., and Garcia A.E. The Alzheimer's peptides Aβ40 and 42 adopt distinct conformations in water: a combined MD/NMR study J. Mol. Biol. 368 2007 1448 1457
32. Lu Y., Derreumaux P., Guo Z., Mousseau N., and Wei G. Thermodynamics and dynamics of amyloid peptide oligomerization are sequence dependent Proteins 75 2008 954 963
33. Cerf E., Sarroukh R., Tamamizu-Kato S., Breydo L., Derclaye S., and Dufrene Y.F. Antiparallel β-sheet: a signature structure of the oligomeric amyloid β-peptide Biochem. J. 421 2009 415 423
34. Yu L., Edalji R., Harlan J.E., Holzman T.F., Lopez A.P., and Labkovsky B. Structural characterization of a soluble amyloid β-peptide oligomer Biochemistry 48 2009 1870 1877
35. Mitternacht S., Staneva I., Härd T., and Irbäck A. Comparing the folding free-energy landscapes of Aβ42 variants with different aggregation properties Proteins 78 2010 2600 2608
36. Bertini I., Gonelli L., Luchinat C., Mao J., and Nesi A. A new structural model of Aβ40 fibrils J. Am. Chem. Soc. 133 2011 16013 16022
37. Crescenzi O., Tomaselli S., Guerrini R., Salvadori S., D'Ursi A.M., Temussi P.A., and Picone D. Solution structure of the Alzheimer amyloid β-peptide (1-42) in an apolar microenvironment Eur. J. Biochem. 269 2002 5642 5648
38. Tomaselli S., Esposito V., Vangone P., Nuland N.A.J.V., Bonvin A.M.J.J., and Guerrini R. The α-to-β conformational transition of Alzheimer's Aβ-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of β conformation seeding ChemBioChem 7 2006 257 267
39. Sciarretta K.L., Gordon D.J., Petkova A.T., Tycko R., and Meredith S.C. Aβ40-lactam (D23/K28) models a conformation highly favorable for nucleation of amyloid Biochemistry 44 2005 6003 6014
40. Hoyer W., Grönwall C., Jonsson A., Ståhl S., and Härd T. Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation Proc. Natl. Acad. Sci. USA 105 2008 5099 5104
41. Nilsberth C., Westlind-Danielsson A., Eckman C.B., Condron M.M., Axelman K., and Forsell C. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation Nat. Neurosci. 4 2001 887 893
42. 1-39 Biochemistry 50 2011 2026 2039
43. Stanger H.E., and Gellman S.H. Rules for antiparallel β-sheet design: d-Pro-Gly is superior to l-Asn-Gly for β-hairpin nucleation J. Am. Chem. Soc. 120 1998 4236 4237
44. Chang E.S.H., Liao T.Y., Lim T.S., Fann W., and Chen R.P.Y. A new amyloid-like β-aggregate with amyloid characteristics, except fibril morphology J. Mol. Biol. 385 2009 1257 1265
45. Haque T.S., Little J.C., and Gellman S.H. Mirror image reverse turns promote β-hairpin formation J. Am. Chem. Soc. 116 1994 4105 4106
46. Haque T.S., and Gellman S.H. Insights on β-hairpin stability in aqueous solution from peptides with enforced type I′ and type II′ β-turns J. Am. Chem. Soc. 119 1997 2303 2304
47. LeVine H. Quantification of β-sheet amyloid fibril structures with thioflavin T Methods Enzymol. 309 1999 274 284
48. O'Nuallain B., Thakur A.K., Williams A.D., Bhattacharyya A.M., Chen S., Thiagarajan G., and Wetzel R. Kinetics and thermodynamics of amyloid assembly using a high-performance liquid chromatography-based sedimentation assay Methods Enzymol. 413 2006 34 74
49. Ferrone F. Analysis of protein aggregation kinetics Methods Enzymol. 309 1999 256 274
50. Knowles T.P.J., Waudby C.A., Devlin G.L., Cohen S.I.A., Aguzzi A., and Vendruscolo M. An analytical solution to the kinetics of breakable filament assembly Science 326 2009 1533 1537
51. O'Nuallain B., Shivaprasad S., Kheterpal I., and Wetzel R. Thermodynamics of Aβ(1-40) amyloid fibril formation Biochemistry 44 2005 12709 12718
52. Williams A.D., Portelius E., Kheterpal I., Guo J.T., Cook K.D., Xu Y., and Wetzel R. Mapping Aβ amyloid fibril secondary structure using scanning proline mutagenesis J. Mol. Biol. 335 2004 833 842
53. Williams A.D., Shivaprasad S., and Wetzel R. Alanine scanning mutagenesis of Aβ(1-40) amyloid fibril stability J. Mol. Biol. 357 2006 1283 1294
54. Sciaretta K.L., Gordon D.J., Petkova A.T., Tycko R., and Meredith S.C. Aβ40-lactam (D23/K28) models a conformation highly favorable for nucleation of amyloid Biochemistry 44 2005 6003 6014
55. Malinchik S.B., Inouye H., Szumowski K.E., and Kirschner D.A. Structural analysis of Alzheimer's β(1-40) amyloid: protofilament assembly of tubular fibrils Biophys. J. 74 1998 537 545
56. Szabó Z., Klement É., Jost K., Zarándi M., Soós K., and Penke B. An FT-IR study of the β-amyloid conformation: standardization of aggregation grade Biochem. Biophys. Res. Commun. 265 1999 297 300
57. Chu H.L., and Lin C.Y. Temperature-induced conformational changes in amyloid β(1-40) peptide investigated by simultaneous FT-IR microspectroscopy with thermal system Biophys. Chem. 89 2001 173 180
58. Greenfield N., and Fasman G.D. Computed circular dichroism spectra for the evaluation of protein conformation Biochemistry 8 1969 4108 4116
59. Dahlgren K.N., Manelli A.M., Stine W.B., Baker L.K., Krafft G.A., and LaDu M.J. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability J. Biol. Chem. 277 2002 32046 32053
60. Stine W.B., Dahlgren K.N., Krafft G.A., and LaDu M.J. In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis J. Biol. Chem. 278 2003 11612 11622
61. Walsh D.M., Townsend M., Podlisny M.B., Shankar G.M., Fadeeva J.V., and Agnaf O.E. Certain inhibitors of synthetic amyloid β-peptide (Aβ) fibrillogenesis block oligomerization of natural Aβ and thereby rescue long-term potentiation J. Neurosci. 25 2005 2455 2462
62. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., and Ashe K.H. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function Nat. Neurosci. 8 2005 79 84
63. 6 Biophys. J. 86 2004 3194 3203
64. Liang Y., Lynn D.G., and Berland K.M. Direct observation of nucleation and growth in amyloid self-assembly J. Am. Chem. Soc. 132 2010 6306 6308
65. Sandberg A., Luheshi L.M., Söllvander S., Barros T.P.D., Macao B., and Knowles T.P.J. Stabilization of neurotoxic Alzheimer amyloid-β oligomers by protein engineering Proc. Natl. Acad. Sci. USA 107 2010 15595 15600
66. C.A. Lasagna-Reeves, C.G. Glabe, and R. Kayed Amyloid-β Annular Protofibrils Evade Fibrillar Fate in Alzheimer's Disease Brain J. Biol. Chem. 286 2011 22122 22130
67. Necula M., Kayed R., Milton S., and Glabe C.G. Small molecule inhibitors of aggregation indicate that amyloid β oligomerization and fibrillization pathways are independent and distinct J. Biol. Chem. 282 2007 10311 10324
68. Choi S., Reixach N., Connelly S., Johnson S.M., Wilson I.A., and Kelly J.W. A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity J. Am. Chem. Soc. 132 2010 1359 1370
69. Ball K.A., Phillips A.H., Nerenberg P.S., Fawzi N.L., Wemmer D.E., and Head-Gordon T. Homogeneous and heterogeneous tertiary structure ensembles of amyloid-β peptides Biochemistry 50 2011 7612 7628
70. Nielsen L., Khurana R., Coats A., Frokjaer S., Brange J., and Vyas S. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism Biochemistry 40 2001 6036 6046
71. Abramoff M.D., Magelhaes P.J., and Ram S.J. Image processing with ImageJ Biophoton. Int. 11 2004 36 42
72. Mehta A.K., Lu K., Childers W.S., Liang Y., Dublin S.N., and Dong J. Facial symmetry in protein self-assembly J. Am. Chem. Soc. 130 2008 9829 9835